Metropolis Healt

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE112L01020
NSEID: METROPOLIS
BSEID: 542650

INR

1,929.85

0.45 (0.02%)

BSENSE

Dec 05

BSE+NSE Vol: 3.93 k

Click here to access the older version

Company CV

About Metropolis Healthcare Ltd

Metropolis Healthcare Ltd

Small Cap

Healthcare Services

Dr. Sushil Kanubhai Shah, one of the Promoters, commenced pathology business in January 1980 as a partnership firm in the name of Dr. V. K. Desai's Hospital, having Dr. Kanubhai M. Shah, Dr. Sushil Kanubhai Shah and Dr. Vasant Kalyandas Desai as partners. The partnership was continued by Dr. Sushil Kanubhai Shah, Dr. Kanubhai M. Shah and Dr. Duru Sushil Shah from September 30, 1981 onwards. In June 1989, upon death of Dr. Kanubhai M. Shah, the partnership was continued by Dr.

Company Coordinates

No Company Details Available

Capital Structure

Present Equity Capital

INR 10.25 Cr

Number of Shares

5.12 Cr

Face Value

INR 2.0

Date

Number
of Shares(Cr)

Equity
Capital (Rs Cr)

Shares Added

Face Value (Rs)

Reason

13-Apr-2024

5.12

10.25

1945

Issued under ESOP Scheme

15-Jan-2024

5.12

10.25

3267

Issued under ESOP Scheme

10-Oct-2023

5.12

10.24

2888

Issued under ESOP Scheme

12-Jul-2023

5.12

10.24

9884

Issued under ESOP Scheme

13-Apr-2023

5.12

10.24

158

Issued under ESOP Scheme

13-Apr-2023

5.12

10.24

158

Issued under ESOP Scheme

07-Jan-2023

5.12

10.24

4372

Issued under ESOP Scheme

13-Oct-2022

5.12

10.24

6043

Issued under ESOP Scheme

13-Oct-2022

5.12

10.24

6043

Issued under ESOP Scheme

14-Jul-2022

5.12

10.24

25502

Issued under ESOP Scheme

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

1.1845

Mutual Funds

Held by 26 Schemes (30.69%)

FIIs

Held by 136 FIIs (12.52%)

Promoter with highest holding

Metz Advisory Llp (30.29%)

Highest Public shareholder

Hdfc Mutual Fund - Hdfc Focused Fund (9.67%)

Individual Investors Holdings

3.69%

Board of Directors

Period

Management

Designation

Remuneration

Sushil Kanubhai Shah

Chairman & Exec. Director

1.8 cr

Ameera Sushil Shah

Managing director

5.24 cr

VIVEK GAMBHIR

Independent Director

11.9 lacs

Sanjay Bhatnagar

Independent Director

7.65 lacs

MILIND SHRIPAD SARWATE

Independent Director

18.05 lacs

Anita Ramachandran

Independent Director

11.5 lacs

Hemant Sachdev

Non-Exec & Non-Independent Dir

Neha Shah

Company Sec. & Compli. Officer

Raw Materials

Raw Materials Dashboard

Raw Materials

Amount(Rs Cr)

% of RM Cost

Raw Materials Consumed

252.6739

Raw Materials Consumed

Finished Goods

Finished Goods Dashboard

Finished Goods

Amount(Rs Cr)

% of Sales Turnover

Pathology and Diagnostic Services

580.20

99.83%

Other Operating Revenue - Sundry Balances Written Back

1.01

0.17%

Pathology and Diagnostic Services

Other Operating Revenue - Sundry Balances Written Back

Stock DNA

Revenue and Profits:

Net Sales:

429 Cr

(Quarterly Results - Sep 2025)

Net Profit:

53 Cr

Industry

Healthcare Services

Market cap

INR 10,001 Cr (Small Cap)

P/E

63.00

Industry P/E

Dividend Yield

0.21%

Debt Equity

0.08

Return on Equity

11.05%

Price to Book

6.96